Showing 61 - 80 results of 306 for search '"kidney transplant"', query time: 0.08s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64

    Fibroblast Growth Factor and Mineral Metabolism Parameters among Prevalent Kidney Transplant Patients by Madhumathi Rao, Priyanka Jain, Temitope Ojo, Gautam Surya, Vaidyanathapuram Balakrishnan

    Published 2012-01-01
    “…To examine mineral metabolism parameters and their relationship to FGF-23 and parathyroid hormone (PTH) in prevalent kidney transplant patients. Methods. Cross-sectional study of 106 kidney transplant patients enrolled November 2005–October 2009 at Tufts Medical Center (TMC), Boston. …”
    Get full text
    Article
  5. 65
  6. 66
  7. 67

    Patient education interventions for adolescent and young adult kidney transplant recipients- a scoping review. by Michael Corr, Clare McKeaveney, Fina Wurm, Aisling Courtney, Helen Noble

    Published 2023-01-01
    “…<h4>Background</h4>Adolescence and young adulthood are high risk periods for kidney transplant recipients. The reasons for this are complex; but are predominantly thought to be due to poor adherence to immunosuppressive medications. …”
    Get full text
    Article
  8. 68

    Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation by Massimiliano Veroux, Tiziano Tallarita, Daniela Corona, Nunziata Sinagra, Alessia Giaquinta, Domenico Zerbo, Carmela Guerrieri, Antonino D'Assoro, Sebastiano Cimino, Pierfrancesco Veroux

    Published 2013-01-01
    “…New-onset diabetes mellitus after transplantation (NODAT) may complicate 2–50% of kidney transplantation, and it is associated with reduced graft and patient survivals. …”
    Get full text
    Article
  9. 69
  10. 70

    Proton Pump Inhibitor-Induced Galactorrhea in a Kidney Transplant Recipient: A Friend or Foe? by Marios Prikis, Julie MacDougall, Nina Narasimhadevara

    Published 2020-01-01
    “…To our knowledge, there have been only three previously reported cases of PPI-induced galactorrhea in the literature but none in a kidney transplant recipient. In patients with established kidney disease and reduced glomerular filtration rate like kidney transplant recipients, the use of PPIs should be thoroughly assessed. …”
    Get full text
    Article
  11. 71
  12. 72

    Massive Leiomyomatous Uterine Proliferation Following Kidney Transplantation: A Case Report and Literature Review by Emmanuel J. Minja, Miguel Tan, Melissa J. Gibbs, Marwan M. Kazimi, Jonathan C. Hundley, Harrison S. Pollinger

    Published 2018-01-01
    “…Despite increasing number of African American females being evaluated for and undergoing kidney transplantation (KT), perioperative management guidelines for uterine fibroids currently do not exist. …”
    Get full text
    Article
  13. 73
  14. 74

    Switching Stable Kidney Transplant Recipients to a Generic Tacrolimus Is Feasible and Safe, but It Must Be Monitored by Fernando González, René López, Elizabeth Arriagada, René Carrasco, Natalia Gallardo, Eduardo Lorca

    Published 2017-01-01
    “…Tacrolimus is the primary immunosuppressive drug used in kidney transplant patients. Replacing brand name products with generics is a controversial issue that we studied after a Chilean Ministry of Health mandate to implement such a switch. …”
    Get full text
    Article
  15. 75
  16. 76

    Eculizumab for Thrombotic Microangiopathy Associated with Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation by Luca Lanfranco, Melanie Joly, Arnaud Del Bello, Laure Esposito, Noelle Cognard, Peggy Perrin, Bruno Moulin, Nassim Kamar, Sophie Caillard

    Published 2017-01-01
    “…Thrombotic microangiopathy is a form of antibody-mediated rejection (ABMR): it is the main complication of ABO-incompatible (ABOi) kidney transplantation (KT). Herein, we report on two cases of ABMR with biological and histological features of thrombotic microangiopathy (TMA) that were treated by eculizumab after ABOi KT. …”
    Get full text
    Article
  17. 77
  18. 78
  19. 79

    Ureteric Trauma following Stent Removal in Kidney Transplant Recipient: A Unique Case of Prolonged Morbidity by Ahmad Mirza, Imran Gani, Andy Shi Huang, Ravi Mallavarapu, Laura Mulloy, Muhammad Saeed, Rajan Kapoor

    Published 2021-01-01
    “…A 52-year-old African-American male patient with end-stage renal disease due to hypertension underwent deceased donor kidney transplant procedure with no immediate complications. …”
    Get full text
    Article
  20. 80